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Abstract
Epstein–Barr virus (EBV) and the closely related Herpesvirus papio (HVP) are stably replicated as episomes in proliferating latently
infected cells. Maintenance and partitioning of these viral plasmids requires a viral sequence in cis, termed the family of repeats (FR), that
is bound by a viral protein, Epstein–Barr nuclear antigen 1 (EBNA1). Upon binding FR, EBNA1 maintains viral genomes in proliferating
cells and activates transcription from viral promoters required for immortalization. FR from either virus encodes multiple binding sites for
the viral maintenance protein, EBNA1, with the FR from the prototypic B95-8 strain of EBV containing 20 binding sites, and FR from HVP
containing 8 binding sites. In addition to differences in the number of EBNA1-binding sites, adjacent binding sites in the EBV FR are
typically separated by 14 base pairs (bp), but are separated by 10 bp in HVP. We tested whether the number of binding sites, as well as
the distance between adjacent binding sites, affects the function of EBNA1 in transcription activation or plasmid maintenance. Our results
indicate that EBNA1 activates transcription more efficiently when adjacent binding sites are separated by 10 bp, the spacing observed in
HVP. In contrast, using two separate assays, we demonstrate that plasmid maintenance is greatly augmented when adjacent EBNA1-binding
sites are separated by 14 bp, and therefore, presumably lie on the same face of the DNA double helix. These results provide indication that
the functions of EBNA1 in transcription activation and plasmid maintenance are separable.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
During latent infection, Epstein–Barr virus (EBV)’s ge-
nome is maintained as a 165-kb plasmid in the nuclei of
infected cells. This plasmid undergoes DNA synthesis once
per cell cycle (Adams, 1987; Yates and Guan, 1991) and
partitions faithfully to daughter nuclei at mitoses (Kirch-
maier and Sugden, 1995; Sugden and Warren, 1988). Ge-
nome maintenance and partitioning requires a single viral
protein, Epstein–Barr nuclear antigen 1 (EBNA1), and a
viral element in cis, oriP (Lupton and Levine, 1985; Reis-
man et al., 1985; Yates et al., 1984). There are two clusters
of binding sites for EBNA1 within oriP, the dyad symmetry
element (DS) that has four sites of lower affinity, and the
family of repeats (FR) (Ambinder et al., 1990; Baer et al.,
1984; Lupton and Levine, 1985; Reisman et al., 1985).
DNA synthesis from oriP initiates at DS (Gahn and Schild-
kraut, 1989); recent evidence indicates that the cellular
origin recognition complex and minichromosome mainte-
nance proteins facilitate that process (Chaudhuri et al.,
2001; Schepers et al., 2001). FR functions as a plasmid
maintenance and partitioning element. FR from the proto-
typic B95-8 strain of EBV contains 20 high-affinity binding
sites for EBNA1. Each site is 16 bp long, and in all but two
instances, adjacent sites are separated by 14 bp (Baer et al.,
1984). When bound to FR, EBNA1 prevents the rapid loss
of oriP-plasmids (Aiyar et al., 1998). It also activates tran-
scription from at least three viral promoters, the BamH1-C
and W promoters (Puglielli et al., 1996), and the promoter
for latent membrane protein 1 (LMP1) (Gahn and Sugden,
1995). EBNA1 and FR have also been characterized to
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activate transcription from heterologous promoters such as
the thymidine kinase promoter of herpes simplex virus 1
(HSV-TK) (Reisman and Sugden, 1986; Wysokenski and
Yates, 1989), the immediate early promoter of human cy-
tomegalovirus (CMV-IE) (Langle-Rouault et al., 1998), and
the long terminal repeat of Rous sarcoma virus (RSV LTR)
(A. Aiyar, unpublished data).
While there is no published isolate of Epstein–Barr virus
that contains fewer than 15 binding sites for EBNA1 in FR,
a virus closely related to EBV, Herpesvirus papio (HVP),
contains only eight EBNA1-binding sites in its FR (Loeb et
al., 1990). The EBNA1 proteins of EBV and HVP are 56%
identical in sequence (Yates et al., 1996). Consistent with
the sequence conservation, Yates and co-workers have dem-
onstrated that the EBNA1 protein of each virus supports
stable replication and maintenance of plasmids containing
the oriP of the other virus. Each protein can also use the
heterologous FR to activate transcription (Yates et al.,
1996). A striking difference between the FRs of EBV and
HVP is that the majority of EBNA1-binding sites in the
latter are separated by 10 bp (Loeb et al., 1990). Because the
periodicity of a DNA double-helix ranges from 10 to 12 bp
(Watson and Crick, 1953), this difference would cause
EBNA1 dimers bound to adjacent binding sites in EBV’s
FR to lie on the same face of the DNA double-helix, while
they would lie on opposite sides in the HVP FR.
Using deletion derivatives of EBV’s FR, Yates and co-
workers demonstrated elegantly that stable maintenance of
oriP-plasmids, and activation of transcription in Raji cells,
required just seven EBNA1-binding sites in FR (Wysoken-
ski and Yates, 1989). In contrast, deletion derivatives with
five EBNA1-binding sites supported plasmid maintenance
to 1% the level of wild-type FR, and transcription activation
to 10% the level of wild-type FR (Wysokenski and Yates,
1989). While this marked decrease is most readily attributed
to a difference in the number of EBNA1-binding sites, it
remains possible that it reflects differences in the affinity of
EBNA1 for individual binding sites. This is because the
individual binding sites in FR differ in sequence, and con-
sequently, in the affinity with which they are bound by
EBNA1 (Ambinder et al., 1990). Consistent with this latter
explanation, these same studies indicated that constructions
with 12 low-affinity EBNA1-binding sites from DS were
also impaired in their ability to support plasmid mainte-
nance in Raji cells and to activate transcription in Raji as
well as Wilson (EBNA1) cells (Wysokenski and Yates,
1989).
To elucidate whether the differences in the space be-
tween adjacent binding sites and binding site number within
FR affect the functions of EBNA1, we have systematically
tested the effects of spacing between adjacent binding sites,
and binding site number on the ability of EBNA1 to activate
transcription or maintain plasmids in proliferating cells. Our
results indicate that EBV’s EBNA1 bound to sites spaced 10
bp apart activate transcription better than binding sites
spaced 14 bp apart. Intriguingly, binding sites spaced 14 bp
apart support plasmid maintenance far more efficiently than
binding sites spaced 10 bp apart.
Results
Design and construction of two sets of synthetic FRs
(sFR)
To determine whether the differences in spacing of ad-
jacent EBNA1-binding sites in the EBV and HVP FR af-
fected either plasmid maintenance or transcription activa-
tion, we created synthetic FRs with increasing numbers of
binding sites that were separated by either 10 or 14 bp. To
eliminate the effect of differences in sequence of individual
EBNA1-binding sites in the wild-type FR, we chose to
construct multimers of the EBNA1-binding site “GGTAG-
CATATGCTATC” that is present at a higher frequency
than any other site in EBV’s FR. Multimers of this site were
created as described under Materials and methods and in-
troduced into transcription and replication reporter plasmids
diagrammed in Fig. 1. Although sFR contain up to 20
identical copies of the same repeat, we did not observe any
change in repeat number or sequence when propagated in
recombination-deficient Escherichia coli strain STBL2
(data not shown).
The spacing between adjacent EBNA1 binding sites
affects transcription activation
EBNA1 activates transcription from at least three EBV
promoters used during latency when bound to FR (Gahn and
Sugden, 1995; Puglielli et al., 1996). This transcription
activation is recapitulated when FR is introduced upstream
of many heterologous promoters (Langle-Rouault et al.,
1998; Reisman and Sugden, 1986; Wysokenski and Yates,
1989). Yates and co-workers (Wysokenski and Yates, 1989)
have previously analyzed the relationship between the num-
ber of EBNA1-binding sites and transcription activation of
the HSV-1 TK promoter in human and rat cells. Their
results indicated that optimal transcription activation re-
quired at least seven EBNA1-binding sites in FR, albeit in
a manner dependent upon the affinity of EBNA1 for the
binding sites. A transcription reporter plasmid with 12 low-
affinity binding sites from DS activated transcription to
20–30% the level of wild-type FR (Wysokenski and Yates,
1989). We have extended this analysis in a manner inde-
pendent of the affinity of individual EBNA1-binding sites
by testing transcription reporter plasmids containing in-
creasing numbers of identical high-affinity EBNA1-binding
sites. Either the control TK-luciferase plasmid, AGP47, or
the derivatives containing 1, 5, 7, 10, or 20 EBNA1-binding
sites separated by 10 or 14 bp were introduced into C33A/
1553 cells, a derivative of C33A cells that express wild-type
EBNA1. An EGFP expression plasmid, 2145, was cotrans-
fected with the luciferase reporter plasmids to normalize for
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transfection efficiency. Cells were harvested at 48 or 96 h
posttransfection and analyzed for luciferase activity as de-
scribed under Materials and methods. The results of these
assays are depicted in fig. 2A and B. By comparing the
graphs in Fig. 2A and B, it can be observed that independent
of the spacing between adjacent EBNA1-binding sites, the
level of luciferase induction at 96 h posttransfection was
lower than the level observed at 48 h posttransfection. This
decrease can be attributed to plasmid loss as a function of
cell division (Aiyar et al., 1998). Forty-eight hours post-
transfection, we observed an increase in luciferase induction
with increasing numbers of EBNA1-binding sites, reaching
a maximum of 110-to 230-fold over the backbone plasmid
that lacked any EBNA1-binding sites for plasmids that
contained 20 EBNA1-binding sites. However, as can be
observed by comparing the solid bars to the hatched bars in
Fig. 2, sFRs wherein adjacent EBNA1-binding sites were
separated by 10 bp activated transcription to a greater level
than the corresponding sFR with a 14-bp spacer between
adjacent binding sites. This correlation was significant, with
a P (two-sided) of 0.005 by the Kendall rank correlation
test, for constructions that contained between 7 and 20
EBNA1-binding sites. Plasmid 985, wild-type FR-TK lucif-
erase, was also tested in this assay. Results from experi-
ments using this plasmid are labeled “wt FR” in Fig. 2 and
indicate that EBNA1 equivalently activates transcription
from a plasmid containing the wild-type FR, or a plasmid
containing an sFR with 20 EBNA1-binding sites spaced 14
bp apart. Results similar to these were obtained from tran-
scription reporter assays performed in 293/EBNA1 cells
(data not shown) and when luciferase activity was measured
96 h posttransfection (Fig. 2B). Overall, three conclusions
can be drawn from these experiments. First, consistent with
the observations of Yates and co-workers (Wysokenski and
Yates, 1989), an increasing number of EBNA1-binding sites
cause increased transcription activation. Second, because
we have used multimers of identical EBNA1-binding sites,
this increase can be attributed to the presence of additional
EBNA1-binding sites on the transcription template, rather
than differences in affinity between individual sites. Finally,
the space between adjacent EBNA1-binding sites influences
transcription activation. EBNA1-binding sites spaced 10 bp
apart were more effective at activating transcription than
EBNA1-binding sites spaced 14 bp apart from each other.
Plasmid maintenance is dramatically influenced by the
space between adjacent EBNA1-binding sites
To investigate whether plasmid maintenance in prolifer-
ating cells is affected by the distance between adjacent
EBNA1-binding sites in FR, the two sets of replication
reporter plasmids described in Fig. 1 were individually
introduced into 293/EBNA1 cells along with the transfec-
tion control, EGFP-expression plasmid 2145. Two days
posttransfection, cells were harvested to measure transfec-
tion efficiency as a function of EGFP expression and then
plated at 2  105, 2  104, or 2  103 cells per 10-cm dish.
Two days after plating, cells were subjected to puromycin
selection for a total of 2 weeks, following which colonies
were stained with methylene blue and counted as described
under Materials and methods. As such, this assay tests the
ability of EBNA1 bound at sFR to maintain and partition the
replication reporter plasmid in proliferating cells and
thereby gives rise to a puromycin-resistant colony. Under
these conditions, transfection of the parental plasmid,
AGP83, that contained DS, but lacked FR, yielded an av-
erage of 2.25 colonies per 105 cells plated. Based on South-
ern hybridization studies (see below and data not shown),
this number reflects the efficiency at which plasmid DNA is
integrated randomly in transfected cells. Several conclu-
sions can be drawn from the results of this assay that are
summarized in Tables 1 and 2.
First, as indicated in Table 1, when sFR contained be-
tween 5 and 10 EBNA1-binding sites, we observed an
Fig. 1. Schematic representations of the transcription and replication reporter plasmids used in this study. The name of each plasmid, the number of
EBNA1-binding sites within the sFR element in the plasmid, and the space between adjacent EBNA1-binding sites in sFR is indicated. Transcription reporter
plasmids contain the firefly luciferase gene under the control of the HSV-1 thymidine kinase promoter. Replication reporter plasmids were constructed using
pPUR as a backbone and contain the DS element from EBV, along with EBV sequences between FR and DS. The location of XbaI and BamHI recognition
sites used in Southern hybridization experiments is indicated.
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increase in colony number as a function of an increasing
number of EBNA1-binding sites. This increase mirrors the
increase previously observed in Raji cells by Yates and
co-workers (Wysokenski and Yates, 1989). However, a
difference between our results and those described previ-
ously lies in the reproducible observation that replication
reporter plasmids with 20 EBNA1-binding sites formed
colonies less efficiently than reporter plasmids with 10
EBNA1-binding sites. The observed decrease was statisti-
cally significant, with a P value of 0.011 when examined by
the Kendall rank correlation test.
Second, the data summarized in Table 1 also indicate that
the distance between adjacent EBNA1-binding sites repro-
ducibly and dramatically influences plasmid partitioning
and maintenance. The efficiency of colony formation is
considerably higher when adjacent EBNA1-binding sites in
sFR are separated by 14 bp than when they are separated by
10 bp. This phenomenon is most apparent when the repli-
cation reporter plasmids contained either 5 or 7 EBNA1-
binding sites in sFR. A plasmid with five binding sites in
sFR spaced 14 bp apart, AGP72, gave rise to colonies with
a 35-fold higher efficiency than AGP88, a plasmid with five
binding sites spaced 10 bp apart in sFR. Similarly, AGP100,
a plasmid whose sFR contains seven binding sites spaced 14
bp apart, gave rise to colonies approximately 10-fold more
efficiently than the corresponding plasmid with seven bind-
ing sites spaced 10 bp apart (AGP89). When examined by
the Wilcoxon rank-sum test (Hollander and Wolfe, 1973),
Fig. 2. EBNA1-binding sites spaced 14 bp apart activate transcription more efficiently in C33A/EBNA1 cells than EBNA1-binding sites spaced 14 bp apart.
Luciferase assays were performed 2 days (A) or 4 days (B) after introducing the transcription reporter plasmids described in Fig. 1 into C33A/1553 cells.
The y-axis represents the fold induction of luciferase activity over that observed with the backbone reporter AGP47 48 h posttransfection, and the number
of binding sites in sFR is indicated on the x-axis. The solid bars represent results from reporters in which adjacent EBNA1-binding sites are separated by
14 bp, while hatched bars represent results from reporters in which adjacent EBNA1-binding sites are separated by 10 bp. wtFR refers to use of the plasmid
985, FR-TK-luciferase, as the transcription reporter.
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both of these differences were found significant, with P
values less than 0.05. An effect of binding site spacing was
also observed when the replication reporter plasmids con-
tained 10 or 20 EBNA1-binding sites in sFR, although this
difference was not as statistically significant as that ob-
served with five or seven EBNA1-binding sites in sFR (P
value  0.06).
Colony formation requires reporter plasmids to undergo
DNA synthesis and to be partitioned at consecutive mitoses.
The failure of a plasmid to support efficient colony forma-
tion can result from a deficiency in DNA synthesis, or from
a defect in maintenance and partitioning. Although none of
the reporter plasmids tested in this study contained differ-
ences in DS, the replication origin within oriP, it is possible
that alterations in FR affect the efficiency with which DNA
synthesis initiates at DS. We therefore examined the effi-
ciency with which reporter plasmids were replicated 4 days
after their introduction into 293/EBNA1 cells, as well as 3
weeks after transfection. If the permutation of EBNA1-
binding sites in sFR primarily affects DNA synthesis, dif-
ferences would be observed at both early and late time
points. In contrast, if the spacing between adjacent EBNA1-
binding sites only affected the levels of replicated reporter
DNA at the later time point, it would indicate that the
permutation of EBNA1-binding sites strongly affects plas-
mid maintenance and partitioning, but not DNA synthesis.
These possibilities were distinguished as described below.
Plasmids AGP83, AGP72, AGP100, AGP73, AGP74,
AGP88, AGP89, AGP90, and AGP91 were introduced into
293/EBNA1 cells. Episomal DNAs were extracted 4 days
posttransfection and then digested with the restriction en-
donuclease DpnI to selectively digest the input unreplicated
DNA as well as the hemimethylated products from the first
round of DNA replication in 293/EBNA1 cells. DpnI-resis-
tant DNAs were digested with XbaI and BamHI, to release
two fragments, labeled A and B, in the representative anal-
ysis shown in Fig. 3. These enzymes were chosen because
the size and sequence of fragment A would be the same for
all the replication reporter plasmids tested. The representa-
tive analysis shown in Fig. 3 indicates that by 4 days
posttransfection all the replication reporters have undergone
at least two rounds of DNA synthesis. The band labeled D
Fig. 3. The distance between adjacent EBNA1-binding sites in sFR and the
number of EBNA1-binding sites in sFR do not affect synthesis of oriP-
plasmids 4 days after their introduction into 293/EBNA1 cells. 293/
EBNA1 cells were transfected with the replication reporter plasmids de-
scribed in Fig. 1. Four days after transfection, episomal DNAs were
recovered from transfected cells, digested with DpnI, BamHI, and XbaI,
and quantified by Southern hybridization. Digested DNA recovered from 1
 107 cells was loaded in each lane. The number of EBNA1-binding sites
in sFR is indicated above each lane, and the spacer between adjacent
EBNA1-binding sites in sFR is indicated in parentheses. DpnI-resistant,
BamHI/XbaI-digested fragments are designated as A and B. The intensity
of A was used to estimate the copy number of newly synthesized plasmids
per cell, by comparison with standards. AGP73 recalcitrant to BamHI-
digestion as described in the text is designated as *. D represents the largest
fragment created after DpnI-digestion of the input bacterially dam-meth-
ylated reporter DNAs.
Table 1
293/EBNA1 cells transfected with replication reporters in which
adjacent EBNA1 binding sites are spaced 14 bp apart form puromycin-
resistant colonies with greater efficiency
Reporter
transfected
EBNA1 binding
sites in sFR
Space between
adjacent sites
Frequency of
puromycin resistance
in plated cellsa
Mock — — 0
AGP83 0 — 2.2  105
AGP72 5 14 1.4 103
AGP88 5 10 4 105
AGP100 7 14 1.2 102
AGP89 7 10 1.1 103
AGP73 10 14 4.4 102
AGP90 10 10 3.5 102
AGP74 20 14 1.3 102
AGP91 20 10 7.6 103
a Data represent the number of puromycin-resistant colonies formed per
105 GFP-positive, live 293/EBNA1 cells plated 48 h posttransfection.
Selection was initiated 4 days posttransfection and maintained for 2 weeks.
Each replication reporter was transfected independently at least two times.
At least two plates were counted from each transfection. Only colonies 2
mm in size and larger were counted.
Table 2
At least four EBNA1 binding sites spaced 14 bp apart are required for
detectable plasmid maintenance in 293/EBNA1 cells
Replication
reporter
EBNA1 binding
sites in sFR
Frequency of puromycin
resistance in plated cellsa
AGP83 0 2.2 105
AGP127 3 3.5 105
AGP128 4 7.9 104
a Data represent the number of puromycin-resistant colonies formed, per
105 GFP-positive, live 293/EBNA1 cells plated 48 h posttransfection.
Selection was initiated 4 days posttransfection. Each replication reporter
was transfected independently at least two times. At least two plates were
counted from each transfection. The number of colonies formed for AGP83
are reproduced from Table 1. Transfections testing the efficiency with
which AGP83 forms puromycin-resistant colonies were performed concur-
rently with transfections testing AGP127 and AGP128.
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represents the largest fragment released after digestion of
the input bacterially dam-methylated replication reporter
plasmids with DpnI. From two independent Southern anal-
yses performed using episomal plasmids extracted from
transfected 293/EBNA1 cells, we estimate that there are
between 5 and 90 DpnI-resistant newly replicated reporter
plasmids present per cell after correcting for transfection
efficiency and are represented in Table 3. A similar range
was observed from one experiment performed using episo-
mal DNAs extracted from C33A/1553 cells 4 days post-
transfection. In all three experiments, AGP73 was incom-
pletely digested by BamHI, resulting in a third DpnI-
resistant fragment in addition to A and B. This band is
labeled as an asterisk in Figs. 3 and 4. It is unclear why this
digestion is incomplete; we have determined that the input
bacterially synthesized AGP73 DNA is completely digested
by BamHI. In addition, plasmid DNAs recovered from bac-
teria transformed with DpnI-resistant AGP73 DNA ex-
tracted from transfected 293/EBNA1 and C33A/1553 cells
are completely susceptible to BamHI digestion and fail to
show any rearrangement in AGP73. Finally, sequence anal-
ysis of AGP73 prior to or after transfection indicates the
BamHI site is intact and is in an identical sequence context
in all the replication reporters tested in this study. Because
this digestion is incomplete, we have quantified the number
of replicated molecules in AGP73 transfected cells using the
sum of the amount of DNA in fragments A and *. It is
emphasized that this incomplete digestion does not affect
the conclusions drawn from this study.
To determine whether the space between adjacent bind-
ing sites in FR affects plasmid maintenance, transfected
cells were subjected to puromycin selection for 3 weeks,
after which episomal plasmids were recovered from pooled
colonies of resistant cells. The recovered plasmids were
digested with DpnI, XbaI, and BamHI and examined by
Southern analysis. Representative results are shown in Fig.
4, which is labeled similarly to Fig. 3. Because this analysis
was performed 3 weeks posttransfection, we do not detect
DpnI-sensitive unreplicated plasmids in episomal plasmids
extracted from cells. Thus the DpnI-resistant fragments,
labeled B in Fig. 4, that vary in size between plasmids, are
not obscured as they are in Fig. 3. The analysis shown in
Fig. 4 indicates that AGP72, AGP100, AGP73, and AGP74
are maintained as episomal plasmids at copy numbers that
vary from approximately 20 (AGP72) to approximately 90
(AGP100, AGP73) copies per puromycin-resistant cell. In
contrast, in the analysis shown in Fig. 4 when adjacent
binding sites in sFR were separated by 10 bp, only plasmids
with 7 (AGP89), 10 (AGP90), or 20 (AGP91) binding sites
were detected as episomal DNAs. AGP88, that contains five
binding sites spaced 10 bp apart, was present at less than
one molecule per cell (0.8 episomal molecules/resistant
cell).
Plasmid maintenance in 293/EBNA1 cells requires at
least four EBNA1-binding sites that are spaced 14 bp
apart
Because the periodicity of the DNA double-helix varies
between 10 and 12 bp, AGP88 and AGP89 are predicted to
maximally contain three or four EBNA1-binding sites, re-
spectively, on one face of the DNA double-helix. Colony
formation assays and Southern blot analyses for episomal
Table 3
Average copy number of replication reporter plasmids during transient
and stable replication assays
Reporter
transfected
EBNA1
binding
sites
in sFR
Space
between
adjacent
sites
Four days
post
transfectiona
Three weeks
post transfectiona
AGP83 0 — 35  14 NDb
AGP127 3 14 47 34 ND
AGP128 4 14 24 8 14  8
AGP72 5 14 72 7 22  15
AGP88 5 10 68 31 0.9  1
AGP100 7 14 35 16 57  16
AGP89 7 10 41 4 8  5
AGP73 10 14 43 22 87  32
AGP90 10 10 65 17 71  14
AGP74 20 14 61 13 33  21
AGP91 20 10 73 28 28  16
a Numbers represent the average number of DpnI-resistant episomal
plasmid molecules per transfected cell detected in three independent ex-
periments along with the standard deviation.
b Not determined.
Fig. 4. EBNA1-binding sites in FR spaced 14 bp apart support stable
replication more effectively than binding sites spaced 10 bp apart. 293/
EBNA1 cells were transfected with the replication reporter plasmids de-
scribed in Fig. 1 and subjected to 3 weeks of puromycin selection. Episo-
mal DNAs were recovered from pools of resistant cells, digested as
described in Fig. 3, and quantified by Southern hybridization. Digested
DNA recovered from 5  106 cells were loaded in each lane. The blot is
labeled as in Fig. 3. The number of EBNA1-binding sites in sFR is
indicated above each lane, and the spacer between adjacent EBNA1-
binding sites in sFR is indicated in parentheses. Measures of 10 pg, 100 pg,
or 1 ng of BamHI/XbaI-digested AGP83 were used as standards during
quantitation. Probe hybridized to the standards is indicated by M1 and M2.
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DNA indicate that AGP88 is not stably maintained. AGP88
is maintained poorly in both these assays, such that in
Southern analysis it is detected at less than one episomal
molecule per transfected cell. In contrast, AGP72, which
contains five EBNA1-binding sites separated by 14 bp,
functions substantially better than AGP88 and slightly bet-
ter than AGP89 (Table 1 and Fig. 4). Therefore two repli-
cation reporters, AGP127 and AGP128, that contain three or
four EBNA1-binding sites separated by 14 bp were con-
structed and used to test the hypothesis that maintenance in
293/EBNA1 cells requires at least four EBNA1-binding
sites on one face of DNA.
AGP127 and AGP128 were tested in colony formation
assays in 293/EBNA1 cells as described previously. The
results of this assay, summarized in Table 2, clearly indicate
that similar to AGP88, AGP127 is not maintained. This
replication reporter cannot be distinguished statistically
from AGP83, a control reporter that contains DS, but not
FR. In contrast, cells transfected with AGP128 formed col-
onies approximately 20–30 times more efficiently. This
efficiency was approximately that observed with AGP89
(compare Tables 1 and 2).
To confirm these results, Southern blot analyses were
performed on episomal plasmids extracted from cells trans-
fected with AGP127 or AGP128. As described earlier, the
copy number of episomal plasmids was determined 4 days
posttransfection, and after 3 weeks of puromycin selection.
These results are shown in Fig. 5 and indicate that episomal,
newly replicated AGP127 and AGP128 can be detected
readily 4 days posttransfection. However, episomal
AGP127 was not detected in extracts from puromycin-
resistant colonies obtained 3 weeks posttransfection. In con-
trast, episomal AGP128 was readily detected at about 14
episomal molecules per transfected cell.
AGP89 and AGP128 behave similarly in two indepen-
dent measures of plasmid maintenance, indicating that al-
though it is inefficient, maintenance of episomal oriP plas-
mids in 293/EBNA1 cells requires a minimum of four
adjacent EBNA1-binding sites on one face of the DNA
helix. Plasmids with three such sites (AGP88, AGP127) fail
to be maintained. Conversely, a plasmid with five such sites
(AGP72) is maintained more efficiently, and the mainte-
nance of a plasmid with seven sites (AGP100) cannot be
distinguished from that of a plasmid with 20 binding sites
(AGP74) either by colony formation assays or by a South-
ern analysis quantifying replicated DNAs.
Discussion
The genomes of EBV and HVP contain a cis-acting
sequence, termed oriP, that facilitates DNA synthesis and
maintenance during latent infection. OriP consists of two
regions, one of which, FR, is required for plasmid mainte-
nance and partitioning. While FR of EBV and HVP both
contain multiple EBNA1-binding sites, they differ in their
organization. EBV’s FR contains 20 EBNA1-binding sites,
the majority of which are separated by 14 bp (Baer et al.,
1984). Because each EBNA1-binding site is 16 bp long, and
the periodicity of the DNA double-helix ranges between 10
and 12 bp, this arrangement is predicted to cause EBNA1
dimers bound to adjacent binding sites to lie on the same
face of the DNA double-helix. The EBNA1-binding sites in
EBV’s FR are not identical in sequence, although they are
all predicted to be bound by EBNA1 with higher affinity
that the sites in EBV’s DS (Ambinder et al., 1990). In
contrast, FR of HVP contains only eight EBNA1-binding
sites, six of which are separated from each other by 10 bp
(Loeb et al., 1990). EBNA1 dimers bound to adjacent sites
in the HVP FR are predicted to lie on approximately oppo-
site faces of the DNA double-helix. Yates and co-workers
have demonstrated that EBNA1 from either HVP or EBV
can function to stably replicate plasmids that contain oriP
from the other virus (Yates et al., 1996). Separately, they
have used deletion mutants to define the minimal sequence
within EBV’s FR that would function to stably replicate
plasmids in cells. Their results indicate that a minimum of
seven EBNA1-binding sites in FR is required for stable
plasmid replication in cells (Wysokenski and Yates, 1989).
We have determined whether EBNA1’s functions are af-
fected by binding site number or the space between adjacent
binding sites by using two sets of constructions with in-
creasing numbers of identical binding sites separated by 10
or 14 bp. Our studies have confirmed the observations of
Yates and co-workers and have extended them in an unex-
pected manner.
As demonstrated previously, transcription activation by
EBNA1 increases with an increasing number of binding
Fig. 5. Maintenance of replicated oriP-plasmids in 293/EBNA1 cells re-
quires at least four EBNA1-binding sites spaced 14 bp apart in sFR.
Replication reporters that contain three binding sites in sFR, AGP127, or
four binding sites, AGP128, were introduced into 293/EBNA1 cells. Epi-
somal DNAs were recovered either 4 days (4d) posttransfection, or from
pooled colonies after 3 weeks (3w) of puromycin selection. The number of
binding sites in sFR is indicated above each lane, and the time posttrans-
fection is indicated in parentheses. Each lane was loaded with DpnI/
BamHI/XbaI-digested DNAs recovered from 1  107 cells (4d) or 2  107
cells (3w).
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sites, as does the ability of EBNA1 to maintain oriP plas-
mids. Surprisingly, both transcription activation and plas-
mid maintenance are affected by the space between adjacent
binding sites. EBNA1 bound to sites spaced 10 bp apart
activated transcription more effectively than EBNA1 bound
to parallel constructions with sites spaced 14 bp apart. This
difference is clearly manifested when the transcription re-
porters are sensitized by decreasing the number of binding
sites to below 10.
Our results indicate that the presence of FR or the num-
ber of binding sites in FR does not affect DNA synthesis
from replication reporter plasmids when assayed 4 days
posttransfection. This observation is similar to recent results
published by the groups of Sugden (Leight and Sugden,
2001) and Yates (Yates et al., 2000). Leight and Sugden
have observed recently that oriP plasmids are rapidly lost
between 5 days and 2 weeks posttransfection, a phenome-
non they have attributed to epigenetic events that allow a
small subset of oriP plasmids to be replicated stably (Leight
and Sugden, 2001). This rapid loss is also evident in results
from the colony formation and Southern hybridization ex-
periments reported in this study. While between 20 and 60%
of cells are detectably transfected by 2 days posttransfec-
tion, less than 5% of these cells proceed to form puromycin-
resistant colonies. In addition, although we detect between 5
and 140 newly replicated molecules per transfected cell 4
days posttransfection, this number is substantially decreased
after 3 weeks of puromycin selection. While the events that
lead to this rapid loss of extrachromosomal plasmids within
a week posttransfection are not understood, our results in-
dicate they are not influenced by the number of EBNA1-
binding sites on the replication reporter, when the reporter
contains anywhere from 5 to 80 EBNA1-binding sites (data
not shown). It is therefore unlikely that the cellular epige-
netic event that allows a subset of oriP plasmids to be
replicated stably involves binding of a cellular protein to
EBNA1-binding sites in FR. Although the EBNA1-binding
sites in the EBV and HVP FR vary considerably in se-
quence, for both viruses the sequence of the spacer between
adjacent binding sites is highly conserved. Because we have
altered the spacer sequence without affecting the ability of
EBNA1 to activate transcription, or maintain plasmids in
proliferating cells, it is unlikely that epigenetic events lead-
ing to stable replication of a subset of plasmids involve the
association of cellular proteins with sequences between ad-
jacent EBNA1-binding sites in FR.
Both the number of binding sites and the distance be-
tween adjacent sites profoundly impact stable replication
and maintenance when assayed 3 weeks posttransfection.
While binding sites spaced 10 bp apart activate transcription
more efficiently, they are far less efficient in plasmid main-
tenance as assayed by colony formation or Southern hybrid-
ization. This decrease in efficiency is most clearly visible
when using replication reporter constructions genetically
sensitized by decreasing the number of binding sites to be
less than 10. Because binding sites spaced 10 bp apart
permit efficient transcription activation by EBNA1, it is
unlikely that their failure to support oriP-plasmid mainte-
nance results from an inability to be bound by EBNA1. For
both sets of replication reporters, we find plasmid mainte-
nance increases with increasing numbers of binding sites. In
293/EBNA1 cells, stable maintenance requires a minimum
of four binding sites, as evidenced by our results with
constructions AGP89 and AGP128. This minimal number
differs between cell lines and is likely a function of the
inherent rate of extrachromosomal plasmid loss for each cell
line (Aiyar et al., 1998). Maintenance in C33A/1553 cells
requires a minimum of five EBNA1-binding sites spaced 14
bp apart (data not shown). The arrangement of the eight
binding sites in the HVP FR predicts that EBNA1 dimers
bound to five of these sites will lie on one face of the DNA
double-helix, suggesting this may be a general minimal
requirement for oriP-plasmid maintenance.
Because the space between adjacent binding sites affects
EBNA1’s functions in oriP-plasmid maintenance, and to a
smaller extent in transcription activation, it is likely that
each of these processes is optimal with a different arrange-
ment of EBNA1 bound to DNA. Schleif and others have
shown that binding-site phasing affects the function of
many prokaryotic transcription activators (Martin et al.,
1986; Schleif, 1996). More recently, studies on the inter-
feron- enhanceosome by the groups of Thanos and Ma-
niatis demonstrate that phasing affects transcription activa-
tion by modulating the ability of proteins within the
enhanceosome to interact with components of the basal
transcription apparatus (Kim and Maniatis, 1997; Merika et
al., 1998). Similar observations have also been made with
an enhanceosome that forms at the early promoter of human
papillomavirus type 18 (Bouallaga et al., 2000). In light of
these results, it is perhaps not surprising that transcription
activation by EBNA1 is affected by surface presented by an
array of EBNA1 dimers on DNA. We find it more surprising
that stable plasmid replication is also affected by phasing.
Because the latter requires efficient DNA synthesis as well
as plasmid maintenance, it is possible that EBNA1 bound at
FR influences the conformation or occupancy of EBNA1 at
DS, a model suggested by the observation that EBNA1 at
FR can interact with EBNA1 at DS, or affect occupancy of
EBNA1 at DS (Su et al., 1991). Consistent with this idea,
EBNA1-binding sites are placed differently in the HVP and
EBV DS elements, which may explain why these viruses
have evolved to contain FR elements wherein EBNA1-
binding sites are phased differently. Alternatively, plasmid
maintenance by EBNA1 may be optimal when EBNA1
dimers are aligned on the same surface of the DNA double-
helix to facilitate interactions with cellular factors required
for maintenance. These two possibilities can be distin-
guished by testing whether the space between adjacent
EBNA1-binding sites in FR affects the maintenance of
plasmids containing a replication origin other than DS, such
as the chromosomal sequences identified by Calos and co-
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workers to function as replication origins in FR-containing
plasmids (Heinzel et al., 1991; Krysan et al., 1989, 1993).
Thus far, it has not been possible to distinguish between
EBNA1’s functions in transcription activation from its func-
tions in plasmid maintenance. Multiple deletion mutations
placed in EBNA1 affect both transcription and plasmid
maintenance in proliferating cells to similar extents (Cec-
carelli and Frappier, 2000; Mackey and Sugden, 1999),
suggesting that both these functions may have a common
underlying mechanism. Rittner and co-workers have ob-
served that transcription from oriP-containing luciferase
reporter plasmids microinjected into the nuclei of 293/
EBNA1 cells is activated to a substantially lower level than
transcription from the same plasmids microinjected into the
cytoplasm (Langle-Rouault et al., 1998). This result was
interpreted to indicate that EBNA1 activates transcription
primarily by facilitating nuclear import and retention of
plasmids, thereby suggesting that transcription activation of
transfected reporter plasmids is a manifestation of EBNA1’s
plasmid maintenance function.
If the ability of EBNA1 to activate transcription, and
stably maintain oriP plasmids, were both only dependent
upon its ability to retain oriP-containing plasmids in the
nuclei of dividing cells, differential effects of binding site
spacing on transcription activation and stable replication
would not have been observed. We interpret the results
described in this article to indicate that the transcription
activation and plasmid maintenance functions of EBNA1
can be distinguished. This is best illustrated when consid-
ering results obtained with transcription and replication re-
porters that contain seven EBNA1-binding sites spaced ei-
ther 10 or 14 bp apart. Seven binding sites spaced 14 bp
apart activate transcription to approximately 50% the level
of seven binding sites spaced 10 bp apart. Results from
plasmid replication and maintenance assays indicate that
seven binding sites spaced 14 bp apart function 10 times as
well as seven binding sites spaced 10 bp apart. This differ-
ence in function strongly suggests that EBNA1 uses differ-
ent mechanisms to activate transcription and to maintain
episomal plasmids.
Finally, the binding site constructions described in this
article can be exploited to understand the relative contribu-
tion of EBNA1 toward transcription activation and genome
maintenance during immortalization of primary B cells by
EBV. Kieff and co-workers have demonstrated that intro-
duction of a dominant negative form of EBNA1 does not
affect the proliferation of IB4, a lymphoblastoid cell line
with integrated EBV genomes. This result is interpreted to
demonstrate that EBNA1’s primary function during immor-
talization is to maintain viral genomes (Hung et al., 2001).
Previously, Speck and co-workers have shown that EBNA1
bound to oriP activates the viral BamHI-C and BamHI-W
promoters that are active during immortalization, suggest-
ing a role for EBNA1’s ability to activate transcription in
immortalization (Puglielli et al., 1996). Replacement of the
wild-type FR with sFRs that preferentially support tran-
scription activation or plasmid maintenance can be used to
discern the contribution of EBNA1 toward each of these
processes during immortalization by EBV. Such studies are
currently in progress.
Materials and methods
Bacterial strains and plasmid purification
All plasmids were propagated in the E. coli strains
DH5, MC1061/P3, or STBL2 (Invitrogen, Carlsbad, CA).
Plasmids used for transfection were purified on isopycnic
CsCl gradients (Sambrook et al., 1989).
Oligonucleotides and plasmids
Oligonucleotides EBNA1-BS1 and EBNA1-BS2 contain a
single high-affinity binding site for EBNA1 flanked by BsrGI
and Acc65I recognition sites as indicated below:
EBNA1-BS1: 5 GATCCTGTACATTAGGATAGC-
ATATGCTACCCAGAGGTACCG
EBNA1-BS2: 5 TCGACGGTACCTCTGGGTAGC-
ATATGCTATCCTAATGTACAG
EBNA1-BS1 and EBNA1-BS2 were annealed and cloned into
plasmid 2275 (Leight and Sugden, 2001) cut with BamHI and
XhoI, to create plasmid AGP6. The complementary 5 over-
hangs created after digestion with the endonucleases Acc65I
and BsrGI sites flanking the EBNA1-binding site in AGP6
were used to create derivatives of AGP6 that contain increas-
ing numbers of EBNA1-binding sites termed synthetic FR. In
the first set of sFRs, adjacent EBNA1-binding sites are sepa-
rated by a spacer of precisely 14 nucleotides with the sequence
“CAGAGGTACATTAG.” A second set of sFRs was created
wherein adjacent EBNA1-binding sites were separated by pre-
cisely 10 bp. For this, two oligonucleotides AGO31 and
AGO32 were synthesized that contain a single high-affinity
binding site for EBNA1 flanked by EcoRI and MfeI recogni-
tion sites as detailed below:
AGO31: 5 TCGAGCAATTGAGGATAGCATATG-
CTACCCAGAATTCG
AGO32: 5 GATCCGAATTCTGGGTAGCATATG-
CTATCCTCAATTGC
AGO111 and AGO112 were annealed and cloned into plasmid
2275 cut with BamHI and XhoI to create plasmid AGP56. The
EcoRI and MfeI sites flanking the EBNA1-binding site in
AGP56 were used to create a series of derivatives of AGP56
that contained an increasing number of EBNA1-binding sites.
In this second set of sFRs, adjacent EBNA1-binding sites are
separated by a spacer of precisely 10 nucleotides with the
sequence “CAGAATTGAG.” pPUR (Clontech, Palo Alto,
CA), a plasmid that contains the puromycin-resistance gene
under the control of the SV40 early promoter, was used as the
backbone to create a series of replication reporter plasmids.
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Two oligonucleotides, AGO19 and AGO20, were used to
amplify all of oriP except FR. This PCR fragment was intro-
duced into pPUR digested with BamHI and BsrGI, to create
AGP83. Both sets of sFRs were introduced into AGP83 in lieu
of FR to create the following set of replication reporter plas-
mids described in Fig. 1. These plasmids were sequenced to
confirm there were no errors in DS, sequences between sFR
and DS, and that they contained the requisite number of
EBNA1-binding sites with the desired spacer between adjacent
binding sites.
Transcription reporters were constructed using AGP47
as the plasmid backbone. AGP47 contains the firefly lucif-
erase gene under the control of the thymidine kinase (TK)
promoter from herpes simplex virus type 1 and was con-
structed by replacing the wild-type FR in plasmid 985
(Middleton and Sugden, 1992) with a multiple cloning site.
Derivatives of AGP47 were constructed that contained ei-
ther set of sFRs introduced into a multiple cloning site
immediately 5 to the TK-luciferase cassette, to create the
transcription reporter plasmid described in Fig. 1. All con-
structed transcription reporter plasmids were sequenced to
ensure there were no errors in the TK promoter and that the
sFRs contained the requisite number of EBNA1-binding sites
with the desired spacer between adjacent binding sites. Se-
quences for all the plasmids used in this study can be found
at the URL http://ebv.mimnet.northwestern.edu/plasmids.
Cell culture and transfections
The human EBNA1 expressing cell lines C33A/1553 and
293/EBNA1 were used in this study. 293/EBNA1 cells are
a derivative of 293 cells (Graham et al., 1977) that stably
express wild-type EBNA1. They were propagated in
DMEM supplemented with 10% fetal bovine serum, G418
(200 mg/L), and antibiotics. C33A/1553 cells are a deriva-
tive of C33A cells (Yee et al., 1985) that stably express
wild-type EBNA1 by carrying integrated copies of the
EBNA1 expression plasmid 1553 (Aiyar and Sugden,
1998). C33A/1553 were grown in DMEM/F12 (1:1) sup-
plemented with 5% calf serum, hygromycin (100 mg/L),
and antibiotics. All cells were grown at 37°C in a humidi-
fied 5% CO2 atmosphere. Plasmids were introduced into
cells by the calcium phosphate method as described previ-
ously (Sambrook et al., 1989). Transfections were normal-
ized by the inclusion of 1 g of a CMV-EGFP expression
plasmid, 2145, in each transfection. Upon harvest, a fraction
of the cells were profiled using a Becton–Dickinson FAC-
Scan or FACScalibur (Franklin Lakes, NJ). Transfection
efficiency was measured as the fraction of GFP-expressing,
live cells quantified using CellQuest software from Becton–
Dickinson.
Transcription reporter assays
One microgram of AGP47, or an equivalent number of
moles of AGP48, AGP50, AGP51, AGP52, AGP53,
AGP92, AGP93, AGP94, or AGP95, was cotransfected
with 1 g 2145 into C33A/1553 cells. Cells were split 8
hours posttransfection so that they would not have reached
confluence when harvested 48 or 96 h posttransfection.
Harvested cells were then counted twice using a Coulter
counter, pelleted, and lysed in reporter lysis buffer (pro-
vided along with a luciferase assay kit from Promega, Mad-
ison, WI) at a concentration of 1  105 cells/l. Lysates
were spun for 5 min at 1000 g to remove nuclei and then
frozen at 80°C until assay. Luminescence assays were
performed as per manufacturer’s instructions, using a Zylux
FB 15 luminometer.
Colony formation assays to assess plasmid maintenance
and partitioning
Fifteen micrograms of AGP83 or an equivalent number
of moles of plasmids AGP72, AGP73, AGP74, AGP100,
AGP127, AGP128, AGP88, AGP89, AGP90, and AGP91
were cotransfected with 1 g of 2145 into 1  107 293/
EBNA1 cells on a 10-cm dish. Cells were split 8 hours
posttransfection so that they would not have reached con-
fluence at 48 h posttransfection. At this time, cells were
harvested, FACS profiled to measure GFP expression, and
replated in duplicate at 2  105, 2  104, and 2  103
GFP-positive, live cells per culture dish. Cells were placed
under selection with 0.5 g/ml puromycin 4 days posttrans-
fection. After 2 weeks of selection, the resulting puromycin-
resistant colonies were fixed with formamide and subse-
quently stained with methylene blue. Colonies that were at
least 2 mm in size were scored as positive.
Southern hybridization analysis to assess plasmid
replication
Fifteen micrograms of AGP83 or an equivalent number
of moles of AGP72, AGP73, AGP74, AGP100, AGP127,
AGP128, AGP88, AGP89, AGP90, AGP91 were cotrans-
fected with 1 g 2145 into 1  107 293/EBNA1 cells on a
10-cm dish. Cells were split 8 h posttransfection so that they
would not be confluent at 96 h posttransfection. At that
time, episomal DNAs were harvested from 2  107 trans-
fected cells, while 1  106 GFP-positive, live cells, as
measured by FACS profiling, were plated per 10-cm dish
for puromycin selection as described above. After 3 weeks
of selection, episomal DNAs were extracted from cells in
puromycin-resistant colonies that were pooled. Episomal
DNAs were extracted from 2  108–108 puromycin-resis-
tant cells as described previously (Aiyar et al., 1998). Ex-
tracted DNAs were digested with 200 units of DpnI, 20
units of BamHI, and 20 units of XbaI in a final volume of
100 l overnight at 37°C. Restriction endonucleases were
purchased from New England Biolabs (Beverly, MA) and
used as per the manufacturer’s instructions. Digestions were
extracted with phenol:chloroform (1:1), precipitated, and
electrophoresed on a 0.8% agarose gel. DNAs were trans-
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ferred from the gel to Hybond membrane (Amersham,
Buckinghamshire, UK) using an Appligene vacuum transfer
apparatus (Boekel Scientific, Feasterville, PA). Radioactive
probes were prepared by the incorporation of [-32P]dCTP
(6000 Ci/mmol) (Amersham) during Klenow synthesis us-
ing random primers and PstI-digested AGP83 as template.
Probe-specific activities ranged from 1  109 to 3  109
cpm/g. Southern hybridization was performed as de-
scribed by Hubert and Laimins (Hubert et al., 1999). South-
ern blots were visualized and quantified by phosphorimage
analysis using a Molecular Dynamics Storm phosphorim-
ager (Molecular Dynamics, Sunnyvale, CA).
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